Beijing Datsing Bio-Tech Co., Ltd.
PrivateLast Round
Private Equity
Jul 10, 2026
Total Funding Raised
$20.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Beijing Datsing Bio-Tech Co., Ltd. is a biotechnology company that develops, manufactures, and markets medical products for wound management, minimally invasive surgery, stomatology, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Datsing Bio-Tech Co., Ltd. Comparables
Compare Beijing Datsing Bio-Tech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Success Bio-Tech Co., Ltd. | 87% | |
| CuraMedical B.V. | 84% | |
| Hangzhou Singclean Medical Products Co., Ltd. | 84% |
Beijing Datsing Bio-Tech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jul 10, 2026 | ||||
| Series C | Jan 1, 2019 | ||||
| Series B | Aug 1, 2014 | ||||
| Series A | May 1, 2013 | ||||
| Seed | Sep 1, 2009 |
Beijing Datsing Bio-Tech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northern Light Venture Capital | Series B |
| China Science and Technology Industry Investment Management | Series C |
| Tsinghua Innovation Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2026
$9.24M round led by Nanjing Pharmaceutical Group Company Limited.
- Jan 1, 2019
Raised Series C round with China Science and Technology Industry Investment Management.
Beijing Datsing Bio-Tech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Datsing Bio-Tech Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Datsing Bio-Tech Co., Ltd. a public or private company?
Beijing Datsing Bio-Tech Co., Ltd. is a private company.
What is the current stock price of Beijing Datsing Bio-Tech Co., Ltd.?
Beijing Datsing Bio-Tech Co., Ltd. is a private company with no public stock price. Caplight tracks Beijing Datsing Bio-Tech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Beijing Datsing Bio-Tech Co., Ltd. worth (valuation)?
Valuation information for Beijing Datsing Bio-Tech Co., Ltd. is not publicly available.
Can I buy Beijing Datsing Bio-Tech Co., Ltd. stock?
Beijing Datsing Bio-Tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Datsing Bio-Tech Co., Ltd.'s last funding round?
Beijing Datsing Bio-Tech Co., Ltd.'s most recent funding round was Private Equity on July 10, 2026.
Who are the main investors in Beijing Datsing Bio-Tech Co., Ltd.?
Key investors in Beijing Datsing Bio-Tech Co., Ltd. include Northern Light Venture Capital, China Science and Technology Industry Investment Management, Tsinghua Innovation Ventures.
Will Beijing Datsing Bio-Tech Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Datsing Bio-Tech Co., Ltd..
How can I track Beijing Datsing Bio-Tech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Datsing Bio-Tech Co., Ltd.'s secondary market activity and sign up for updates.